Myeloproliferative diseases

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

Check conditions None

Apply sex-specific rule None

diagram downward connector MYELOPROF

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 1083 579 504
Unadjusted prevalence (%) 0.42 0.39 0.45
Mean age at first event (years) 60.01 59.32 60.79

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.99 [2.59, 6.16] 3.8e-10 173
15 years 0.03 4.20 [2.75, 6.40] 2.5e-11 161
5 years 0.01 6.79 [4.76, 9.68] 3.9e-26 86
1 year - - - -

Correlations

Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: 7

Survival analyses between endpoints

Plot

before Myeloproliferative diseases
after Myeloproliferative diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases